These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27832787)

  • 21. Comprehensive profiling of protein lysine acetylation in Escherichia coli.
    Zhang K; Zheng S; Yang JS; Chen Y; Cheng Z
    J Proteome Res; 2013 Feb; 12(2):844-51. PubMed ID: 23294111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The E. coli sirtuin CobB shows no preference for enzymatic and nonenzymatic lysine acetylation substrate sites.
    AbouElfetouh A; Kuhn ML; Hu LI; Scholle MD; Sorensen DJ; Sahu AK; Becher D; Antelmann H; Mrksich M; Anderson WF; Gibson BW; Schilling B; Wolfe AJ
    Microbiologyopen; 2015 Feb; 4(1):66-83. PubMed ID: 25417765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perspectives of inclusion bodies for bio-based products: curse or blessing?
    Slouka C; Kopp J; Spadiut O; Herwig C
    Appl Microbiol Biotechnol; 2019 Feb; 103(3):1143-1153. PubMed ID: 30569219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of inclusion body formation and its correlation with the characteristics of protein aggregates in Escherichia coli.
    Upadhyay AK; Murmu A; Singh A; Panda AK
    PLoS One; 2012; 7(3):e33951. PubMed ID: 22479486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Influence of the reductase deficient Escherichia coli on the solubility of recombinant proteins produced in it].
    Xiong S; Zhang MY; Qian CW; Ran YC; Wang YF; Ren XR; Su KY; Yu ZY
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):686-91. PubMed ID: 15971580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a rapid high-efficiency scalable process for acetylated Sus scrofa cationic trypsin production from Escherichia coli inclusion bodies.
    Zhao M; Wu F; Xu P
    Protein Expr Purif; 2015 Dec; 116():120-6. PubMed ID: 26318238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent.
    Upadhyay V; Singh A; Jha D; Singh A; Panda AK
    Microb Cell Fact; 2016 Jun; 15():100. PubMed ID: 27277580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overproduced Brucella abortus PdhS-mCherry forms soluble aggregates in Escherichia coli, partially associating with mobile foci of IbpA-YFP.
    Van der Henst C; Charlier C; Deghelt M; Wouters J; Matroule JY; Letesson JJ; De Bolle X
    BMC Microbiol; 2010 Sep; 10():248. PubMed ID: 20920169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversibly acetylated lysine residues play important roles in the enzymatic activity of Escherichia coli N-hydroxyarylamine O-acetyltransferase.
    Zhang QF; Gu J; Gong P; Wang XD; Tu S; Bi LJ; Yu ZN; Zhang ZP; Cui ZQ; Wei HP; Tao SC; Zhang XE; Deng JY
    FEBS J; 2013 May; 280(9):1966-79. PubMed ID: 23452042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterizing Lysine Acetylation of Isocitrate Dehydrogenase in Escherichia coli.
    Venkat S; Chen H; Stahman A; Hudson D; McGuire P; Gan Q; Fan C
    J Mol Biol; 2018 Jun; 430(13):1901-1911. PubMed ID: 29733852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teaching an old pET new tricks: tuning of inclusion body formation and properties by a mixed feed system in E. coli.
    Wurm DJ; Quehenberger J; Mildner J; Eggenreich B; Slouka C; Schwaighofer A; Wieland K; Lendl B; Rajamanickam V; Herwig C; Spadiut O
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):667-676. PubMed ID: 29159587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetyl-phosphate is a critical determinant of lysine acetylation in E. coli.
    Weinert BT; Iesmantavicius V; Wagner SA; Schölz C; Gummesson B; Beli P; Nyström T; Choudhary C
    Mol Cell; 2013 Jul; 51(2):265-72. PubMed ID: 23830618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active inclusion body formation using Paenibacillus polymyxa PoxB as a fusion partner in Escherichia coli.
    Park SY; Park SH; Choi SK
    Anal Biochem; 2012 Jul; 426(1):63-5. PubMed ID: 22490467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Method for Inclusion Bodies Production via E. coli Host System: rGCSF as Model Biotherapeutic Protein.
    Rani AK; Naira VR; Rathore AS
    Methods Mol Biol; 2023; 2617():249-256. PubMed ID: 36656530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysine acetylation is a highly abundant and evolutionarily conserved modification in Escherichia coli.
    Zhang J; Sprung R; Pei J; Tan X; Kim S; Zhu H; Liu CF; Grishin NV; Zhao Y
    Mol Cell Proteomics; 2009 Feb; 8(2):215-25. PubMed ID: 18723842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of active inclusion bodies in the periplasm of Escherichia coli.
    Arié JP; Miot M; Sassoon N; Betton JM
    Mol Microbiol; 2006 Oct; 62(2):427-37. PubMed ID: 17020581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational analyses of Cry protein block7 polypeptides that facilitate the formation of protein inclusion in Escherichia coli.
    Hayakawa T; Shimizu Y; Ishida T; Sakai H
    Appl Microbiol Biotechnol; 2011 Jun; 90(6):1943-51. PubMed ID: 21468710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-throughput recovery of therapeutic proteins from the inclusion bodies of Escherichia coli: an overview.
    Panda AK
    Methods Mol Biol; 2005; 308():155-61. PubMed ID: 16082033
    [No Abstract]   [Full Text] [Related]  

  • 39. Quality comparison of recombinant soluble proteins and proteins solubilized from bacterial inclusion bodies.
    López-Cano A; Sicilia P; Gaja C; Arís A; Garcia-Fruitós E
    N Biotechnol; 2022 Dec; 72():58-63. PubMed ID: 36150649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Title: insoluble proteins catch heterologous soluble proteins into inclusion bodies by intermolecular interaction of aggregating peptides.
    Carratalá JV; Cisneros A; Hellman E; Villaverde A; Ferrer-Miralles N
    Microb Cell Fact; 2021 Feb; 20(1):30. PubMed ID: 33531005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.